RESUMO
Objective To enhance the cognition about the adult contagious atypical pneumonia for an expectation of earlier diagnosis, prevention and treatment.Methods We analyzed and summarized X-ray lung and clinical characteristics of 34 patients with contagious atypical pneumonias who were admitted to our hospital from Feb to April. 2003.Results X-ray findings of lung were characterized by mostly involving unilateral and presenting ill defined cloud or patches-form opacities. These lesions progressed and varied rapidly. The clinical manifestations were characterized by the onset of fever (34/34), mostly associated with systemic and joint aching pains (29/34) and dry coughs (29/34). Leucocyte counts showed normal or lower than normal. Patient with a continuing high fever might tend to develop ARDS (2/34). All the 34 patients recovered after combined therapies (anti-inflammation, anti-virus and promoting immunity ) and were discharged from hospital. The average in-hospital days were (10.6?4.2) days. Conclusion X-ray examination is the main method for the early diagnosis and observing state-variation. The predominant clinical features of this disease are fever, dry cough, aching pain in extremities, unconspicuous pulmonary signs as well as hemogram not rising, a continuing high fever may lead to the tendency of ARDS.
RESUMO
This paper reports diagnostic results of 200 cases of hemoptysis. The causes of hemoptysis mainly include: bronchial and pulmonary infections (28%), tracheal,bronchial and pulmonary tumor (22.5%),tuberculosis (9.5%), pulmonary abscess (4%), other pulmonary diseases (2.5%), dosprders pitside the lungs (6.5%), and diseases of unidentified reason (5.5%). The diagnostic procedure of hemoptysis is also discussed. It is especially emphasized that the Pulmonary biopsy via bronchia and technique of systematic segmental lavage are of crucial importance for the diagnosis of hemoptysis.
RESUMO
10?g/L may be very valuable for diagnosis of lung cancer, especially for adenocarcinoma. Cyfra21-1 and NSE were better biomarkers for squamous cell carcinoma and SCLC, respectively. The combined detection of Cyfra21-1 and CEA could be used as a better pattern for diagnosis of lung cancer.